Category: Series
-
Aequus Pharmaceuticals (AQS.V) Sees All, Partners with ReVision Therapeutics to Tackle Stargardt Disease
I have a bit of a sweet tooth. When I was little, my dad used to buy me those massive 64-ounce Jelly Belly containers from Costco. Even that wasn’t enough to satiate my craving for sugar seeing as I would finish the entire thing in just a few days. Eventually, I grew out of my…
-
Five Easy Questions with Maddy – Technical Trading Explained
Ever wondered about the weird world of technical trading? Always thought head and shoulders was only a reference to dandruff shampoo? Equity Guru’s Maddy Grace speaks with EG’ chart expert, Vishal Toora, to get a breakdown of technical trading, reading charts and the $1000 secret!! Tune in!
-
Today’s Idea: Get Your Game On, with GameOn Entertainment Technologies (GET.C)
GameOn Entertainment Technologies Inc. GameOn Entertainment Technologies Inc. (GET.C) is a leading technology company powering the most-watched content in the world. How? Through its unique offering of white label engagement technologies, which the Company provides to broadcasters, TV networks, OTT platforms, leagues, tournaments, sportsbooks, and even NFTs with interactive, social experiences centered around sports, television,…
-
GameOn Entertainment Technologies (GET.C) – Five Easy Questions with Maddy
This week Maddy speaks with Matt Bailey, founder and CEO of GameOn Entertainment Technologies (GET.C) and gets an inside look at the company’s efforts to revolutionize superfan engagement for sports as well as its aim to amplify user engagement for the financial sector and traditional media. Enjoy!
-
Canntab Therapeutics (PILL.C): a pressing investment opportunity – Today’s Idea
Canntab Therapeutics (PILL.C) has been around the block and then some. The Ontario-based pharmaceutical answer to medicinal cannabis, has pioneered a patented process to turn CBD, THC and terpene and other cannabinoid distillates into hard-pressed pills that reliably deliver accurately measured dosages with optimal bioavailability. The company’s instant release and extended-release formulations round out a…
-
Canntab Therapeutics (PILL.C) Enters Agreement with 36Eight Technologies
Canntab Therapeutics (PILL.C) announced today that it has reached an agreement with 36Eight Technologies (“36Eight”), whereby “36Eight” will list, market, and support all of Canntab’s market-exclusive and patent-protected solid and exact dose products. “This is an exciting opportunity for Canntab, as we believe 36Eight’s unique and valuable complementary platform will support our ability to provide…
-
Graphene Manufacturing Group (GMG.V) produces laboratory-grade graphene from methane gas
Eight years ago, Physics World published an article announcing that graphene was a “miracle substance” so strong that a sheet of graphene the thickness of “Clingfilm” could support the weight of an elephant. “Graphene is a layer of carbon just one atom thick and since it was first isolated in 2004 its remarkable electronic and…
-
EG Founder Chris Parry’s Advice to CEOs Ahead of Investor Conf. Season – First Glance With Jody Vance (E70)
In this episode of First Glance, Jody chats with Equity Guru Founder and CEO Chris Parry to see what advice or tip he has for CEOs as we get closer to the upcoming Investor Conference Season. Tune In!